login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
BIORESTORATIVE THERAPIES INC (BRTX) Stock News
USA
-
Nasdaq
- NASDAQ:BRTX -
US0906556065
-
Common Stock
1.04
USD
0 (0%)
Last: 12/2/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
BRTX Latest News, Press Relases and Analysis
All
Press Releases
13 days ago - By: Chartmill
- Mentions:
PBM
HUSA
FOSL
CMCT
...
Traders are paying attention to the gapping stocks in Thursday's session.
13 days ago - By: Benzinga
- Mentions:
GRI
PBM
SCLX
PACS
...
12 Health Care Stocks Moving In Thursday's Intraday Session
13 days ago - By: Benzinga
- Mentions:
PBM
PACS
ZYXI
INM
...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
16 days ago - By: BioRestorative Therapies, Inc
BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease
20 days ago - By: The Motley Fool
BioRestorative (BRTX) Earnings Call Transcript
21 days ago - By: Zacks Investment Research
- Mentions:
TOI
Biorestorative Therapies, Inc. (BRTX) Reports Q3 Loss, Lags Revenue Estimates
23 days ago - By: Zacks Investment Research
- Mentions:
CRSP
CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates
a month ago - By: BioRestorative Therapies, Inc
BioRestorative Therapies to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025
a month ago - By: BioRestorative Therapies, Inc
BioRestorative Awarded Notice of Allowance for Japanese Patent – Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market
a month ago - By: BioRestorative Therapies, Inc
BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio
2 months ago - By: BioRestorative Therapies, Inc
BioRestorative Therapies to Participate in the 2025 Maxim Growth Summit
2 months ago - By: Zacks Investment Research
Is Bayer (BAYRY) Outperforming Other Medical Stocks This Year?
2 months ago - By: BioRestorative Therapies, Inc
BioRestorative CEO Lance Alstodt Interviewed on “The Big Biz Show”
2 months ago - By: BioRestorative Therapies, Inc
BioRestorative Therapies Announces $1.085 Million Registered Direct Offering Priced Above Market
4 months ago - By: Zacks Investment Research
- Mentions:
BDTX
Are Medical Stocks Lagging Black Diamond Therapeutics (BDTX) This Year?
4 months ago - By: Zacks Investment Research
Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Beats Revenue Estimates
4 months ago - By: Zacks Investment Research
- Mentions:
ZYME
Zymeworks Inc. (ZYME) Tops Q2 Earnings and Revenue Estimates
4 months ago - By: Zacks Investment Research
- Mentions:
TRDA
Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Lags Revenue Estimates
4 months ago - By: BioRestorative Therapies, Inc
BioRestorative Therapies to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025
6 months ago - By: BioRestorative Therapies, Inc
BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates
6 months ago - By: BioRestorative Therapies, Inc
BioRestorative Announces Share Repurchase Program
6 months ago - By: BioRestorative Therapies, Inc
BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease
6 months ago - By: BioRestorative Therapies, Inc
BioRestorative Welcomes Serial Regenerative Medicine Entrepreneur, Company Builder and Leader, Sandy Lipkins, to BRTX Team
6 months ago - By: BioRestorative Therapies, Inc
BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025
7 months ago - By: Zacks Investment Research
- Mentions:
CGEN
Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Lags Revenue Estimates
7 months ago - By: Zacks Investment Research
- Mentions:
STOK
Stoke Therapeutics, Inc. (STOK) Tops Q1 Earnings and Revenue Estimates
7 months ago - By: BioRestorative Therapies, Inc
Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data
7 months ago - By: Zacks Investment Research
- Mentions:
CHRS
Coherus BioSciences (CHRS) Reports Q1 Loss, Lags Revenue Estimates
Please enable JavaScript to continue using this application.